Visceral therapeutics is an emerging Canadian biotechnology company harnessing the best-in-class research scientists in biotechnology to provide a unique solution to unmet medical needs in the gastrointestinal (GI) space...
Visceral is a bio-pharmaceutical company that specializes in the development of novel, cannabinoid-based therapeutics by augmenting the efficacy of safe therapeutics with the synergistic effects of CB-1 and CB-2 receptor activity...
We are building a technologically advanced bio-pharmaceutical company that will bridge the patient gap between conventional pharmaceuticals and cannabinoid science.